Cardiovascular screening prior to stem cell transplantation in the United Kingdom

eJHaem

article

David G. Gent¹  Muhammad Saif²  Julia Lee³  Arpad G. Tóth²  Eleni Tholouli⁴  Rebecca Dobson¹  David J. Wright¹ 

[1]Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital

[2]The Clatterbridge Cancer Centre

[3]British Society of Blood and Marrow Transplantation and Cellular Therapy Data Registry

[4]Department of Haematology, Manchester University NHS Foundation Trust

关键词: cardiovascular screening;    hematopoietic cell transplantation;    stem cell transplantation;   

DOI  :  10.1002/jha2.599

来源: Wiley

【 摘 要 】

Haematopoietic cell transplantation (HCT) recipients experience anincreased risk of cardiovascular disease compared to the general population[1, 2]. Although transplant-related mortality has decreased overthe last decades, this has not been through a reduction in death dueto cardiovascular disease [3, 4]. Improving cardiovascular outcomespost-transplant is a focus of the International Cardio-Oncology Society [5], and the European Society of Cardiology has recently producedguidelines for risk assessment and surveillance.

【 授权许可】

Unknown